Guidelines for Acalculous Cholecystitis
Critical Note: Evidence Limitation
The provided evidence primarily addresses acute calculous cholecystitis (ACC - with gallstones), not acalculous cholecystitis (AAC - without gallstones). The WSES 2020 guidelines 1 focus on calculous disease. However, I will extract applicable principles and supplement with the limited AAC-specific research provided.
Diagnosis
Use abdominal ultrasound as the first-line imaging modality 1. Look specifically for:
- Gallbladder wall thickening ≥3.5 mm (most reliable criterion) 2
- Pericholecystic fluid (second most reliable criterion) 2
- Positive sonographic Murphy's sign
- Absence of gallstones (distinguishes AAC from calculous disease)
Diagnostic accuracy of ultrasound for AAC is high when properly performed 2, though the WSES guidelines note heterogeneity in diagnostic performance for acute cholecystitis generally (sensitivity 50-100%, specificity 33-100%) 1.
For indeterminate cases, consider:
- CT scan for better visualization and to exclude alternative diagnoses 3
- Hepatobiliary scintigraphy (HIDA scan) reserved for unclear cases 4, 3
Risk Stratification
AAC occurs predominantly in critically ill patients 3, 5, 6, 2. Key risk factors include:
- Critical illness requiring ICU care
- Sepsis from other sources
- Cardiovascular disease (myocardial infarction, congestive heart failure - the only independent risk factor for death) 5
- Major trauma or burns
- Prolonged mechanical ventilation
- Total parenteral nutrition
- Diabetes mellitus
- Malignancy
- Post-viral illness (in children)
Severity grading using Tokyo Guidelines criteria (validated for acute cholecystitis generally) 7:
- Grade I (mild): No organ dysfunction
- Grade II (moderate): Elevated WBC >18,000, palpable mass, symptoms >72 hours, marked local inflammation
- Grade III (severe): Any organ dysfunction (cardiovascular, neurologic, respiratory, renal, hepatic, hematologic)
Management Algorithm
For Surgical Candidates (Even High-Risk Patients)
Immediate laparoscopic cholecystectomy is the first-choice treatment, even in high-risk patients 1. This recommendation is based on the CHOCOLATE trial showing:
- 5% complication rate with early laparoscopic cholecystectomy vs. 53% with drainage alone
- Equal mortality between groups
- Significantly fewer recurrent biliary events
- Less healthcare resource utilization
This applies to AAC patients who can tolerate general anesthesia 5, 6. The Japanese nationwide survey found laparoscopic cholecystectomy had preferable outcomes compared to other approaches in AAC 5.
Perform subtotal cholecystectomy if complete dissection is unsafe due to severe inflammation or unclear anatomy 1.
For Patients NOT Suitable for Surgery
Reserve percutaneous cholecystostomy (PC) for patients who are truly not surgical candidates 1. This includes:
- Patients with uncontrolled sepsis who cannot tolerate general anesthesia
- Extreme physiologic derangement beyond what risk scores capture
- Specific surgeon judgment that surgery would be futile or impossible
Gallbladder drainage converts a septic AAC patient into a non-septic patient 1. PC has:
- 85% success rate in controlling disease 2
- 0.36% procedure-related mortality
- 15.4% 30-day mortality (reflecting underlying illness severity) 1
After PC placement and clinical improvement, interval cholecystectomy is usually NOT indicated for AAC 2. If gallstone absence is confirmed and the precipitating illness has resolved, remove the tube after recovery.
Antibiotic Management
Initiate broad-spectrum antibiotics immediately 1, 4, 3:
For uncomplicated AAC:
- Piperacillin-tazobactam (excellent biliary penetration) 1
- Ceftriaxone + metronidazole
- Ciprofloxacin + metronidazole (for β-lactam allergy)
For complicated AAC or septic patients:
- Carbapenems (imipenem, meropenem, or ertapenem) 4
- Piperacillin-tazobactam
- Consider broader coverage based on local resistance patterns
Obtain bile cultures in complicated cases or high-risk patients (immunocompromised, healthcare-associated infection) and adjust antibiotics based on sensitivities 1.
Key Clinical Pitfalls
Do not assume all critically ill patients with AAC require drainage instead of surgery. The CHOCOLATE trial definitively showed surgery is superior even in high-risk patients (APACHE 7-14) 1.
Distinguish between "high-risk" and "not suitable for surgery." High-risk patients (defined by APACHE score, comorbidities, age >80) should still undergo cholecystectomy 1. Only reserve drainage for patients where surgery is genuinely impossible or futile.
AAC has substantially worse outcomes than calculous cholecystitis 8, with higher complication rates, greater morbidity burden (Clavien-Dindo ≥IIIa), and markedly higher 30-day mortality. This mandates aggressive early treatment and intensive monitoring.
Beware diagnostic mimics. Renal pathology (acute pyelonephritis) can cause reactive gallbladder changes that mimic AAC on ultrasound 9. Use CT when clinical picture is atypical.
Pathogenesis involves ischemia-reperfusion injury and bile stasis 2, not just infection. Address underlying precipitants (shock, vasopressor use, mechanical ventilation, TPN) alongside definitive treatment.
Timing
Perform cholecystectomy as early as safely possible - ideally within 72 hours of symptom onset, though this is extrapolated from calculous cholecystitis data 1.
For PC, perform within 24-48 hours if conservative management fails 1. Predictors of conservative management failure include:
- Age >70 years
- Diabetes
- Tachycardia
- WBC >15,000/mm³
- Fever
- Distended gallbladder on imaging